“…The use of nanotechnology in drug delivery holds great promise for the development of new and innovative approaches to combat SSIs and other infections. [3] SLNs Solid lipid nanoparticles (SLNs) have gained significant attention in recent years as an alternate carrier system for delivering various molecules, including drugs, nucleic acids, proteins, peptides, nutraceuticals, and cosmetics. They offer several advantages over conventional carriers such as liposomes, polymeric nanoparticles, and inorganic carriers, including ease of preparation, physicochemical stability, scalability, and biocompatibility.…”